CRISPR Cas9 Patent Landscape Report

James H. Moeller - Moeller Ventures LLC - https://www.moellerventures.com/
Date: 2022-07-06

How to Use this report:

  • Use the Table of Contents below to navigate to specific sections by clicking on the headings.

  • The HTML version of this report provides interactive figures and tables, with mouse-over, zoomable data display, and searchable, sortable tables. This provides the user with the capability to further explore the landscaping results.

  • This report is updated on an as-needed basis.

Overview:

The PatSnap Connected Innovation Intelligence platform was used to execute this patent landscape analysis. PatSnap’s semantic search capability was used to generate the domain collection by executing 28 separate semantic queries using each of the documents named in the February 28th USPTO PTAB Interference decision. Each semantic query yields up to 1,000 of the most semantically similar patent documents. These queries were first executed as two subdomains and stored as separate workspaces within PatSnap. The first was for the 14 documents from the Berkeley group, which consists of the University of California Berkeley, the University of Vienna, and scientist Emmanuelle Charpentier, who was formerly associated with the University of Vienna, collectively referred to as “CVC” in the Interference decision. The second subdomain consists of the 14 documents from the Broad Institute group, consisting of The Broad Institute, the Massachusetts Institute of Technology, and Harvard University, collectively referred to as “Broad” in the Interference decision. These subdomains were then combined into a single workspace so that the results of the 28 semantic queries were aggregated into a final domain collection for analysis. As the query results and subdomains are combined into a single workspace, duplicate patent documents are deleted automatically by the PatSnap tool. For the 14 patent documents assigned to the CVC group, this process resulted in a subdomain collection of 1,382 patent documents consisting of 373 simple patent families. For the 14 patent documents assigned to the Broad Institute group, this process resulted in a subdomain of 2,967 patent documents consisting of 757 simple families. Combing the two subdomains to produce the final domain collection resulted in a workspace with 3,455 patent documents consisting of 859 simple patent families. The patent document landscaping analysis was performed on this workspace.



Summary of the Fundamental CRISPR Patent Documents
  • This is a summary table of the fundamental CRISPR patent documents that have been used as seeds in semantic queries to create the domain collection.
  • These are the 28 patent documents named in the February 28, 2022 USPTO PTAB Interference Proceeding.
  • Click on column headings to sort.
  • Use the Search boxes to search on any column.

IndexPatent or Application #EntityGoogle Publication Number LinkedTitleApplication Filing DatePriority ToEarliest Priority Date
0 15/947,680 CVC US20180230495A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 4/6/2018 US201261652086P, and others. 5/25/2012
1 15/947,700 CVC US20180230496A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 4/6/2018 US201261652086P, and others. 5/25/2012
2 15/947,718 CVC US20180230497A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 4/6/2018 US201261652086P, and others. 5/25/2012
3 15/981,807 CVC US20180251793A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 5/16/2018 US201261652086P, and others. 5/25/2012
4 15/981,808 CVC US20180251794A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 5/16/2018 US201261652086P, and others. 5/25/2012
5 15/981,809 CVC US20180251795A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 5/16/2018 US201261652086P, and others. 5/25/2012
6 16/136,159 CVC US20190002921A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 9/19/2018 US201261652086P, and others. 5/25/2012
7 16/136,165 CVC US20190002922A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 9/19/2018 US201261652086P, and others. 5/25/2012
8 16/136,168 CVC US20190002923A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 9/19/2018 US201261652086P, and others. 5/25/2012
9 16/136,175 CVC US20190010520A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 9/19/2018 US201261652086P, and others. 5/25/2012
10 16/276,361 CVC US20190169645A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 2/14/2019 US201261652086P, and others. 5/25/2012
11 16/276,365 CVC US20190169646A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 2/14/2019 US201261652086P, and others. 5/25/2012
12 16/276,368 CVC US20190169647A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 2/14/2019 US201261652086P, and others. 5/25/2012
13 16/276,374 CVC US20190169648A1 Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription 2/14/2019 US201261652086P, and others. 5/25/2012
14 8,697,359 Broad US8697359B1 CRISPR-Cas systems and methods for altering expression of gene products 10/15/2013 US201261736527P, and others. 12/12/2012
15 8,771,945 Broad US8771945B1 CRISPR-Cas systems and methods for altering expression of gene products 2/18/2014 US201261736527P, and others. 12/12/2012
16 8,795,965 Broad US8795965B2 CRISPR-Cas component systems, methods and compositions for sequence manipulation 2/18/2014 US201261736527P, and others. 12/12/2012
17 8,865,406 Broad US8865406B2 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation 3/24/2014 US201261736527P, and others. 12/12/2012
18 8,871,445 Broad US8871445B2 CRISPR-Cas component systems, methods and compositions for sequence manipulation 4/23/2014 US201261736527P, and others. 12/12/2012
19 8,889,356 Broad US8889356B2 CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes 2/18/2014 US201261736527P, and others. 12/12/2012
20 8,895,308 Broad US8895308B1 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation 6/2/2014 US201261736527P, and others. 12/12/2012
21 8,906,616 Broad US8906616B2 Engineering of systems, methods and optimized guide compositions for sequence manipulation 5/29/2014 US201261736527P, and others. 12/12/2012
22 8,932,814 Broad US8932814B2 CRISPR-Cas nickase systems, methods and compositions for sequence manipulation in eukaryotes 4/22/2014 US201261736527P, and others. 12/12/2012
23 8,945,839 Broad US8945839B2 CRISPR-Cas systems and methods for altering expression of gene products 4/18/2014 US201261736527P, and others. 12/12/2012
24 8,993,233 Broad US8993233B2 Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains 12/12/2013 US201261736527P, and others. 12/12/2012
25 8,999,641 Broad US8999641B2 Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains 3/26/2014 US201261736527P, and others. 12/12/2012
26 9,840,713 Broad US9840713B2 CRISPR-Cas component systems, methods and compositions for sequence manipulation 10/24/2014 US201261736527P, and others. 12/12/2012
27 14/704,551 Broad US20150247150A1 Engineering of systems, methods and optimized guide compositions for sequence manipulation 5/5/2015 US201261736527P, and others. 12/12/2012



Summary of All Patent Documents in Ungrouped Domain Collection
  • This is a summary table of the all the patent documents in the domain collection. The domain collection consists of 3,455 patent documents consisting of 859 simple patent families.
  • Many of these documents could be duplicates of the same patent application or granted patent in different countries.
  • Click on column headings to sort.
  • Use the Search boxes to search on any column.

Index Publication Date Application Date Issue Date Application Number Publication Number Simple Family Current Assignee Country Title Abstract (Translated) Claims Standardized Current Assignee PatSnap Publication Number Linked Google Publication Number Linked



Summary of the Top Current Assignee Regions (grouped data by patent family)
  • This is a summary table of the top current assignee countries and tabulates the countries of assignees across all grouped patent families in the domain collection.
  • This table is designed to show the geographic concentrations of the owners of the intellectual property.
  • For the CRISPR domain collection this is indicating that the assignees of the fundamental IP largely reside in the United States, which is not unexpected given that the initial patent filings in this IP sector were by the Berkeley group and the Broad Institute group.
Top_Current_Assignee_Regions_TableOnly.png



Simple Legal Status of Patent Documents (grouped data by patent family)
  • This is a summary table of the simple legal status of the patent documents in the domain collection and presents the data corresponding to the filing stages of the documents.
  • The PCT (Patent Cooperation Treaty) classifications refer to the initial filing stages of internationally designated patent applications.
  • The Pending classification refers to applications that are pending in national stage examinations.
  • Active classification refers to granted patents.
  • This chart is often useful in providing insight into the maturity of an IP sector.
  • For the CRISPR domain collection, it is indicating that it’s still early in the evolution of this IP sector as 45% of the patent families are still in pending stage and only approximately 20% have been granted.
Simple_Legal_Status_grouped_20220606.jpg



Applications and Granted Patents Timeline (grouped data by patent family)
  • The applications and granted patents timeline provides a concise view of the historic trends of patenting activity embodied in the domain collection.
  • The chart shows the number of granted patents resulting from applications filed in the same year.
  • This is helpful for understanding the application filing rate as well as the grant rate for the IP sector. The application filing rate can be an indicator of the IP competitive landscape and the grant rate can an indicator of the approval environment.
  • Also note that the most recent data (the most recent ~18-24 months) is likely only partial data, as there are publishing delays and sometimes long pendency times (time between application and grant approval) associated with various patent jurisdictions.
  • For the CRISPR domain collection the increasing application numbers and the decreasing grant rate both indicate an increasingly competitive environment with more applications being filed and fewer granted patents being allowed on a percentage basis. The current grant rate for this IP sector is approximately 10%.
Applications_Grants_Trends_20220526-grouped-InsightsTechnologyReportOnline.jpg



Top 100 Inventors (grouped data by patent family)
  • This shows the top 100 inventors for the CRISPR domain collection and essentially lists the individuals who are the top intellectual property experts.
  • For the CRISPR domain collection this list is led by individuals associated with the Broad Institute group and the Berkeley group.
  • Click on column headings to sort.
  • Use the Search boxes to search on any column.

IndexInventor NameNumber of Patent Documents
0 ZHANG, FENG 78
1 CHURCH, GEORGE M. 21
2 DOUDNA, JENNIFER A. 20
3 ZETSCHE, BERND 14
4 RAN, FEI 13
5 BARRANGOU, RODOLPHE 12
6 王帅 11
7 王永明 11
8 胡子英 11
9 CONG, LE 10
10 JOUNG, J. KEITH 10
11 王大奇 10
12 FRISCH, RYAN L. 9
13 MAY, ANDREW PAUL 9
14 BANFIELD, JILLIAN F. 8
15 COX, DAVID BENJAMIN TURITZ 8
16 CRAWLEY, ALEXANDRA BRINER 8
17 SCOTT, DAVID A. 8
18 URNOV, FYODOR 8
19 ABUDAYYEH, OMAR O. 7
20 ALTAE-TRAN, HAN 7
21 CHENG, DAVID R. 7
22 CHOUDHARY, AMIT 7
23 CIGAN, ANDREW MARK 7
24 DUCHATEAU, PHILIPPE 7
25 GARST, ANDREW 7
26 KHALILI, KAMEL 7
27 KIANI, SAMIRA 7
28 KONERMANN, SILVANA 7
29 ROUBOS, JOHANNES ANDRIES 7
30 YAN, WINSTON X. 7
31 YOUNG, JOSHUA K. 7
32 DAVIS, GREGORY D. 6
33 DONOHOUE, PAUL DANIEL 6
34 GILL, RYAN T. 6
35 GOOTENBERG, JONATHAN 6
36 HEIDENREICH, MATTHIAS 6
37 HSU, PATRICK 6
38 KLEINSTIVER, BENJAMIN 6
39 LIU, DAVID R. 6
40 LIU, DAVID, R. 6
41 NISHIDA, KEIJI 6
42 PLATT, RANDALL JEFFREY 6
43 SANJANA, NEVILLE ESPI 6
44 SLAYMAKER, IAN 6
45 VAN DER OOST, JOHN 6
46 YANG, LUHAN 6
47 ALEXANDER, LISA 5
48 ANDERSON, DANIEL G. 5
49 BROWN, CHRISTOPHER 5
50 BURSTEIN, DAVID 5
51 BUTTERFIELD, CRISTINA 5
52 CHAVEZ, ALEJANDRO 5
53 CHEN, FUQIANG 5
54 DEVOTO, AUDRA 5
55 GREGORY, PHILIP D. 5
56 HARRINGTON, LUCAS BENJAMIN 5
57 HOLMES, MICHAEL C. 5
58 JANTZ, DEREK 5
59 KONDO, AKIHIKO 5
60 LUNDBERG, ANTE SVEN 5
61 MALI, PRASHANT G. 5
62 SHALEM, OPHIR 5
63 SMITH, JAMES JEFFERSON 5
64 THOMAS, BRIAN 5
65 VERWAAL, RENÉ 5
66 WANG, JIANBIN 5
67 YIN, HAO 5
68 ZAMBROWICZ, BRIAN 5
69 AUERBACH, WOJTEK 4
70 BARAM, DAVID 4
71 BAUER, DANIEL E. 4
72 BLAINEY, PAUL 4
73 BOWEN, TYSON D. 4
74 CHOUDHURY, SOURAV 4
75 COCO, WAYNE 4
76 COHNEN, ANDRE 4
77 COST, GREGORY J. 4
78 COYLE, MICHAEL 4
79 DAHLMAN, JAMES E. 4
80 EBRAHIMKHANI, MO REZA 4
81 ELICH, TEDD D. 4
82 ESVELT, KEVIN M. 4
83 FAN, XIAOCHUN 4
84 FRENDEWEY, DAVID 4
85 GERSBACH, CHARLES A. 4
86 GERSBACH, CHARLES, A. 4
87 GIELESEN, BIANCA ELISABETH MARIA 4
88 HONG, SEUNG-PYO 4
89 HOU, ZHENGLIN 4
90 HUMMEL, AARON 4
91 IZHAR, LIOR 4
92 KANNAN, SOUMYA 4
93 KANTOR, ROSE 4
94 KARVELIS, TAUTVYDAS 4
95 KING, MATTHEW G. 4
96 KONG, LING-JIE 4
97 LAWIT, SHAI JOSHUA 4
98 LIN, CHIE-YU 4
99 LIN, HAINING 4



Top 100 Standardized Current Assignees (grouped data by patent family)
  • This shows the top 100 standardized current assignees. The standardization of assignees in this list is a process within PatSnap where assignees and tabulations of patent documents are aggregated to account for M&A transactions and situations where an assignee is a division of a parent corporation.
  • Click on column headings to sort.
  • Use the Search boxes to search on any column.

IndexStandardized Current AssigneeNumber of Patent Documents
0 MASSACHUSETTS INST OF TECH 111
1 BROAD INSTITUTE 103
2 PRESIDENT & FELLOWS OF HARVARD COLLEGE 78
3 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 45
4 SANGAMO BIOSCIENCES INC 17
5 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV 16
6 CRISPR THERAPEUTICS AG 15
7 NORTH CAROLINA STATE UNIVERSITY 15
8 PIONEER HI-BRED INT INC 13
9 THE GENERAL HOSPITAL CORP 13
10 DUKE UNIV 12
11 THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK 12
12 CARIBOU BIOSCI 12
13 FUDAN UNIV 11
14 SIGMA ALDRICH CO LLC 11
15 CHILDRENS MEDICAL CENT CORP 10
16 UNIV OF MASSACHUSETTS 10
17 THE BRIGHAM & WOMENS HOSPITAL INC 10
18 INSCRIPTA INC 9
19 REGENERON PHARM INC 9
20 EDITAS MEDICINE 9
21 ARBOR BIOTECH INC 9
22 THE TRUSTEES OF THE UNIV OF PENNSYLVANIA 8
23 ROCKEFELLER UNIV THE 8
24 TEMPLE UNIVERSITY 8
25 DSM IP ASSETS BV 7
26 ARIZONA STATE UNIVERSITY 7
27 TOOLGEN 7
28 DANISCO US INC 7
29 CELLECTIS SA 7
30 PAIRWISE PLANTS SERVICES INC 6
31 THE JOHN HOPKINS UNIV SCHOOL OF MEDICINE 6
32 WHITEHEAD INST FOR BIOMEDICAL RES 6
33 PRECISION BIOSCI 6
34 AGILENT TECH INC 6
35 KOBE UNIVERSITY 6
36 UNIV OF WASHINGTON 6
37 WAGENINGEN UNIV 5
38 VERTEX PHARMA INC 5
39 EMENDOBIO INC 5
40 RUTGERS UNIVERSITY 5
41 BRAIN AG 5
42 RGT UNIV OF MINNESOTA 4
43 INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM) 4
44 BAYER HEALTHCARE LLC 4
45 CENT NAT DE LA RECHERCHE SCI 4
46 UNIV OF COLORADO THE REGENTS OF 4
47 MONSANTO TECH LLC 4
48 LIFEEDIT INC 4
49 DUPONT US HLDG LLC 4
50 INST FOR BASIC SCI 3
51 UNIV OF SOUTHERN CALIFORNIA 3
52 INTEGRATED DNA TECHNOLOGIES 3
53 CHRISTIANA CARE HEALTH SERVICES 3
54 IZHAR LIOR 3
55 TECHNICAL UNIVERSITY OF DENMARK 3
56 SUN YAT-SEN UNIV 3
57 INARI AGRI INC 3
58 NOVOZYMES AS 3
59 APPL STEMCELL INC 3
60 US DEPT OF HEALTH 3
61 WISCONSIN ALUMNI RES FOUNDATION 3
62 ASTRAZENECA AB 3
63 JACKSON LABORATORY 3
64 OHIO STATE INNOVATION FOUND 3
65 QINGDAO AGRI UNIV 3
66 METAGENOMI INC 3
67 THE UNIV OF TOKYO 3
68 DEUTES KREBSFORSCHUNGSZENT STIFTUNG DES OFFENTLICHEN RECHTS 3
69 ZYMERGEN INC 3
70 BARAM DAVID 3
71 KATHOLIEKE UNIVERSITEIT LEUVEN 3
72 METAGENOMI IP TECH LLC 3
73 INTELLIA THERAPEUTICS INC 3
74 PEIKING UNIVERSITY 3
75 INST OF ZOOLOGY CHINESE ACAD OF SCI 3
76 EMORY UNIVERSITY 3
77 THE UNIV OF NORTH CAROLINA AT CHAPEL HILL 3
78 MONTANA STATE UNIVERSITY 3
79 THE CHILDRENS HOSPITAL OF PHILADELPHIA 2
80 UNIV OF MARYLAND 2
81 CHINA AGRI UNIV 2
82 UNIV OF IOWA RES FOUND 2
83 THE CHINESE UNIVERSITY OF HONG KONG 2
84 AVELLINO LAB USA 2
85 THE CATHOLIC UNIVERSITY OF AMERICA 2
86 OSAKA UNIV 2
87 DIAMANT NOAM 2
88 ALLEN INST 2
89 YALE UNIV 2
90 BANFIELD JILLIAN F 2
91 UNIVERSITY OF HEIDELBERG 2
92 CHAN ZUCKERBERG BIOHUB INC 2
93 LARIX BIOSCI 2
94 IOWA STATE UNIV RES FOUND 2
95 ETH ZZURICH 2
96 LEXICON PHARM INC 2
97 NOVARTIS AG 2
98 THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS 2
99 STICHTING VOOR DE TECH WETENSCHAPPEN 2



Top 50 Most Cited Patent Documents (grouped data by patent family)
  • This shows the most cited patent documents across all the documents in the domain collection and can help identify foundational prior art and important patent references as well as additional IP competitors (assignees) in the sector.
  • A cited patent document is typically a patent application or granted patent that is considered significant (prior art, or in some way relevant) to the patent application that cites it.
  • The table below thus represents the list of the top 50 most cited patent document references on granted patents and patent applications in the CRISPR domain collection.
  • Click on column headings to sort.
  • Use the Search boxes to search on any column.

IndexPatSnap Publication Number LinkedGoogle Publication Number LinkedTitleApplication DatePublication DateStandardized Current AssigneeCount of Cited by Patents
0 WO2013141680A1 WO2013141680A1 RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX 2013-03-15 2013-09-26 VILNIUS UNIVERSITY 440
1 US20110207221A1 US20110207221A1 Targeted genomic modification with partially single-stranded donor molecules 2011-02-09 2011-08-25 SANGAMO BIOSCIENCES INC 371
2 US20150098954A1 US20150098954A1 Compositions and Methods Related to CRISPR Targeting 2013-10-08 2015-04-09 ELWHA LLC 200
3 WO2014093479A1 WO2014093479A1 Crispr (clustered regularly interspaced short palindromic repeats) RNA-guided control of gene regulation 2013-12-11 2014-06-19 MONTANA STATE UNIVERSITY 178
4 US10017760B2 US10017760B2 Methods for generating barcoded combinatorial libraries 2017-06-23 2018-07-10 UNIV OF COLORADO THE REGENTS OF | INSCRIPTA INC 145
5 US20160168592A1 US20160168592A1 Multiplex RNA-Guided Genome Engineering 2014-07-08 2016-06-16 PRESIDENT & FELLOWS OF HARVARD COLLEGE 140
6 US20150044772A1 US20150044772A1 Crispr/cas system-based novel fusion protein and its applications in genome editing 2014-08-08 2015-02-12 SAGE LABS 136
7 US20150291965A1 US20150291965A1 Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains 2015-06-12 2015-10-15 BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | PRESIDENT & FELLOWS OF HARVARD COLLEGE 135
8 US20150024499A1 US20150024499A1 Modified cascade ribonucleoproteins and uses thereof 2014-07-08 2015-01-22 CARIBOU BIOSCI 135
9 US20160289673A1 US20160289673A1 Optimized small guide rnas and methods of use 2014-09-29 2016-10-06 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 125
10 WO2012088381A2 WO2012088381A2 Continuous directed evolution 2011-12-22 2012-06-28 PRESIDENT & FELLOWS OF HARVARD COLLEGE | LIU DAVID R | ESVELT KEVIN M | CARLSON JACOB CHARLES 120
11 US20140349405A1 US20140349405A1 Rna-directed DNA cleavage and gene editing by cas9 enzyme from neisseria meningitidis 2014-05-22 2014-11-27 WISCONSIN ALUMNI RES FOUNDATION | NORTHWESTERN UNIV 117
12 US20160340662A1 US20160340662A1 Engineering of systems, methods and optimized guide compositions for sequence manipulation 2016-08-05 2016-11-24 PRESIDENT & FELLOWS OF HARVARD COLLEGE | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH 107
13 US20150191744A1 US20150191744A1 Cas9 effector-mediated regulation of transcription, differentiation and gene editing/labeling 2014-12-16 2015-07-09 UNIV OF CENT FLORIDA RES FOUND INC | UNIV OF MASSACHUSETTS 89
14 US20170022499A1 US20170022499A1 Methods and compositions for the production of guide RNA 2015-04-03 2017-01-26 MASSACHUSETTS INST OF TECH 81
15 WO2014194190A1 WO2014194190A1 Gene targeting and genetic modification of plants via RNA-guided genome editing 2014-05-30 2014-12-04 PENN STATE RES FOUND 80
16 US20160153004A1 US20160153004A1 Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells 2015-12-16 2016-06-02 BROAD INSTITUTE | MASSACHUSETTS INST OF TECH 76
17 US20170029805A1 US20170029805A1 Methods and compositions for modifying genomic DNA 2015-04-13 2017-02-02 MAXCYTE 73
18 US20170198269A1 US20170198269A1 Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation 2016-11-07 2017-07-13 PRESIDENT & FELLOWS OF HARVARD COLLEGE | BROAD INSTITUTE | MASSACHUSETTS INST OF TECH 72
19 US6207371B1 US6207371B1 Indexed library of cells containing genomic modifications and methods of making and utilizing the same 1997-10-02 2001-03-27 LEXICON PHARM INC 65
20 WO2016115355A1 WO2016115355A1 RNA guided eradication of herpes simplex type i and other related herpesviruses 2016-01-14 2016-07-21 TEMPLE UNIVERSITY 61
21 US20160298096A1 US20160298096A1 Crispr-cas system materials and methods 2014-11-17 2016-10-13 CRISPR THERAPEUTICS AG 60
22 WO2017127807A1 WO2017127807A1 Crystal structure of crispr cpf1 2017-01-23 2017-07-27 BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | THE UNIV OF TOKYO | US DEPT OF HEALTH | YAMANO TAKASHI | NISHIMASU HIROSHI | ZETSCHE BERND | SLAYMAKER IAN | LI YINQING | FEDOROVA IANA | MAKAROVA KIRA | GAO LINYI | KOONIN EUGENE | ZHANG FENG | NUREKI OSAMU 60
23 US9822370B2 US9822370B2 Method of making a deletion in a target sequence in isolated primary cells using Cas9 and two guide RNAs 2014-09-12 2017-11-21 PRESIDENT & FELLOWS OF HARVARD COLLEGE | CHILDRENS MEDICAL CENT CORP 58
24 WO2017015015A1 WO2017015015A1 Crispr-associated protein from francisella and uses related thereto 2016-07-13 2017-01-26 EMORY UNIVERSITY 56
25 US20150110762A1 US20150110762A1 Delivery methods and compositions for nuclease-mediated genome engineering 2014-10-16 2015-04-23 SANGAMO BIOSCIENCES INC 54
26 US20180135073A1 US20180135073A1 Crispr-based genome modification and regulation 2017-07-18 2018-05-17 SIGMA ALDRICH CO LLC 53
27 WO2018213708A1 WO2018213708A1 Systems, methods, and compositions for targeted nucleic acid editing 2018-05-18 2018-11-22 BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | PRESIDENT & FELLOWS OF HARVARD COLLEGE 52
28 US20170198302A1 US20170198302A1 Methods and systems for targeted gene manipulation 2016-11-17 2017-07-13 THE CHINESE UNIVERSITY OF HONG KONG 51
29 US20150315576A1 US20150315576A1 Genetic device for the controlled destruction of DNA 2013-11-01 2015-11-05 MASSACHUSETTS INST OF TECH 50
30 WO2016176191A1 WO2016176191A1 Dual aav vector system for crispr/cas9 mediated correction of human disease 2016-04-26 2016-11-03 THE TRUSTEES OF THE UNIV OF PENNSYLVANIA 45
31 US20160340661A1 US20160340661A1 Delivery, use and therapeutic applications of the crispr-cas systems and compositions for genome editing 2016-06-10 2016-11-24 BROAD INSTITUTE | MASSACHUSETTS INST OF TECH 41
32 US20160102324A1 US20160102324A1 New compact scaffold of cas9 in the type ii crispr system 2014-05-28 2016-04-14 CELLECTIS SA 37
33 WO2018074979A1 WO2018074979A1 Truncated crispr-cas proteins for DNA targeting 2017-10-17 2018-04-26 NANYANG TECH UNIV | AGENCY FOR SCI TECH & RES 37
34 WO2019005886A1 WO2019005886A1 Crispr/cas-cytidine deaminase based compositions, systems, and methods for targeted nucleic acid editing 2018-06-26 2019-01-03 BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | PRESIDENT & FELLOWS OF HARVARD COLLEGE | KANNAN SOUMYA 37
35 WO2016097751A1 WO2016097751A1 Method of cas9 mediated genome engineering 2015-12-18 2016-06-23 UNIVERSITY OF BATH 36
36 WO2016069910A1 WO2016069910A1 Methods for efficient delivery of therapeutic molecules in vitro and in vivo 2015-10-29 2016-05-06 MASSACHUSETTS EYE & EAR INFARY 35
37 US20160324938A1 US20160324938A1 Sequence specific antimicrobials 2016-05-20 2016-11-10 ROCKEFELLER UNIV THE 35
38 US20170020922A1 US20170020922A1 Gene editing for immunological destruction of neoplasia 2016-07-06 2017-01-26 BATU BIOLOGICS 35
39 WO2015127428A1 WO2015127428A1 Methods for in vivo genome editing 2015-02-24 2015-08-27 MASSACHUSETTS INST OF TECH 34
40 WO2016070070A1 WO2016070070A1 RNA guided eradication of human jc virus and other polyomaviruses 2015-10-30 2016-05-06 TEMPLE UNIVERSITY 34
41 WO2016182893A1 WO2016182893A1 Functional genomics using crispr-cas systems for saturating mutagenesis of non-coding elements, compositions, methods, libraries and applications thereof 2016-05-06 2016-11-17 BROAD INSTITUTE | MASSACHUSETTS INST OF TECH | CHILDRENS MEDICAL CENT CORP 33
42 US20170058272A1 US20170058272A1 Directed nucleic acid repair 2016-08-31 2017-03-02 CARIBOU BIOSCI 32
43 US7361641B2 US7361641B2 Methods and compositions for genomic modification 2003-08-05 2008-04-22 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV 31
44 WO2017189336A1 WO2017189336A1 Methods and compositions for genomic editing 2017-04-20 2017-11-02 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 31
45 WO2017024047A1 WO2017024047A1 Compositions and methods for increasing nuclease induced recombination rate in cells 2016-08-03 2017-02-09 EMENDOBIO INC | IZHAR LIOR | BARAM DAVID | DIAMANT NOAM 28
46 WO2017123609A1 WO2017123609A1 Compositions and methods for enhanced genome editing 2017-01-11 2017-07-20 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 28
47 WO2017161068A1 WO2017161068A1 Mutant cas proteins 2017-03-16 2017-09-21 PRESIDENT & FELLOWS OF HARVARD COLLEGE 27
48 WO2017040786A1 WO2017040786A1 Multilayer genetic safety kill circuits based on single cas9 protein and multiple engineered grna in mammalian cells 2016-09-01 2017-03-09 MASSACHUSETTS INST OF TECH 26
49 WO1999007389A1 WO1999007389A1 Targeted gene discovery 1998-08-06 1999-02-18 LEXICON PHARM INC 26



Technology Classification Code Analysis (grouped data by patent family)
  • Patent document technology classification codes are often utilized to gain insight into the technology applied in an IP sector or domain collection by analyzing the patent document information, the assigned class codes, and the description of those class codes.
  • Classification codes are assigned to every patent document to categorize the inventive ideas. Patent documents can be assigned multiple classification codes representing each potentially different inventive idea embodied in the patent filing.
  • The tables below show the break-down of the technology classification codes as applied to the patent documents of the top assignees. The first table shows the top five classification codes applied to all patent documents in the domain collection as well as the corresponding descriptions. The second table then shows the tabulation of the top five class codes as applied to the patent documents of the top 10 assignees.
  • In a general sense this shows the broader areas of focus for those top assignees.
Top_5_IPC_Codes.png



Top_5_IPC_Codes_of_Top_10_Assignees.png



Landscape Diagram Image Analysis (ungrouped data by patent family)
  • Patent landscape diagramming is a versatile technique that can be used to visualize and explore a patent document domain collection.
  • The main landscape diagram is generated via natural language processing (NPL) and semantically similar text clustering of the patent documents in the domain collection. A topographical diagram is generated using all the documents of the domain collection with topographical peaks representing higher concentrations of patent documents and troughs representing areas with lower concentrations or no patent documents at all. Textbox callouts are then generated for the higher concentrations and significantly differentiated text clusters.
  • The diagram below shows the topographical landscape diagram created from the 3,455 ungrouped patent documents of the CRISPR domain collection. Textbox callouts have been automatically added for the NLP-derived clusters of patent documents. Red and yellow dots have been added to the diagram that represent the patent documents assigned to the entities of the Berkeley group (yellow dots) and the Broad Institute group (red dots). This visualization shows how the semantic analysis algorithm has differentiated the focus areas of the two research organizations, with the Berkeley group patent documents mostly in the upper-left corner of the diagram and the Broad Institute group documents in the lower-left corner.
CRISPR-Cas9_landscape_screenshot_20220607131558-cropped.png





------End of HTML Report------